These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 31853695)
41. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells. Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636 [TBL] [Abstract][Full Text] [Related]
42. CENPA facilitates glioma stem cell stemness and suppress ferroptosis to accelerate glioblastoma multiforme progression by promoting GBP2 transcription. Li C; Jing J; Wang Y; Jiang H Pathol Res Pract; 2024 Aug; 260():155438. PubMed ID: 38964117 [TBL] [Abstract][Full Text] [Related]
43. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation. Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536 [TBL] [Abstract][Full Text] [Related]
44. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038 [TBL] [Abstract][Full Text] [Related]
45. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1. Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170 [TBL] [Abstract][Full Text] [Related]
47. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation. Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714 [TBL] [Abstract][Full Text] [Related]
49. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo. Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059 [TBL] [Abstract][Full Text] [Related]
50. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells. Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222 [TBL] [Abstract][Full Text] [Related]
51. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563 [TBL] [Abstract][Full Text] [Related]
52. Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells Through Regulation of HOX Gene Expression. Xia H; Liu Y; Wang Z; Zhang W; Qi M; Qi B; Jiang X Neurotherapeutics; 2020 Apr; 17(2):754-764. PubMed ID: 31691127 [TBL] [Abstract][Full Text] [Related]
54. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970 [TBL] [Abstract][Full Text] [Related]
55. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Tilghman J; Wu H; Sang Y; Shi X; Guerrero-Cazares H; Quinones-Hinojosa A; Eberhart CG; Laterra J; Ying M Cancer Res; 2014 Jun; 74(11):3168-79. PubMed ID: 24710409 [TBL] [Abstract][Full Text] [Related]
56. CSNK1D is associated with stemness and invasiveness in glioblastoma. Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821 [TBL] [Abstract][Full Text] [Related]
57. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells. Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897 [TBL] [Abstract][Full Text] [Related]
58. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1. Wang Y; Cheng Y; Yang Q; Kuang L; Liu G J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917 [TBL] [Abstract][Full Text] [Related]
59. Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop. Wang J; Xu SL; Duan JJ; Yi L; Guo YF; Shi Y; Li L; Yang ZY; Liao XM; Cai J; Zhang YQ; Xiao HL; Yin L; Wu H; Zhang JN; Lv SQ; Yang QK; Yang XJ; Jiang T; Zhang X; Bian XW; Yu SC Nat Neurosci; 2019 Jan; 22(1):91-105. PubMed ID: 30559479 [TBL] [Abstract][Full Text] [Related]
60. Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway. Yan GN; Yang L; Lv YF; Shi Y; Shen LL; Yao XH; Guo QN; Zhang P; Cui YH; Zhang X; Bian XW; Guo DY J Pathol; 2014 Sep; 234(1):11-22. PubMed ID: 24604164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]